However, ultrasound plus AFP’s limited sensitivity and specificity has reduced its reliability as a primary screening modality for HCC [8,9], and more sensitive biomarkers for HCC are desired [6]. The gene discussed is AFP; the disease is hepatocellular carcinoma.